Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT01677975 | The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma | unknown | N/A | — | Rigshospitalet, DenmarkOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00003828 | S9804: Vinorelbine in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 24 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00104988 | S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 64 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00062933 | A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT01294735 | Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) | completed | Phase 1 | 19 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00506311 | Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients | completed | N/A | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00527761 | Taxotere/Temodar/Cisplatin Study in Melanoma Patients | completed | Phase 1 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00014625 | E7070 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 24, 2012 | clinicaltrials |
| NCT00085059 | Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma | terminated | Phase 2 | 4 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00003989 | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00023647 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 26 | Mannkind CorporationINDUSTRY | 1 | Jul 10, 2012 | clinicaltrials |
| NCT00002669 | Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 90 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00094107 | Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00077532 | Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 179 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00085462 | Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 61 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 22, 2012 | clinicaltrials |
| NCT01161888 | Effect of Topical Imiquimod on Lentigo Maligna(LIMIT-1) | completed | Phase 4 | 30 | Jerry MarsdenOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01620749 | Of 18F MEL050 Using PET/CT in Metastatic Melanoma(MEL050) | unknown | Early Phase 1 | 12 | Cooperative Research Centre for Biomedical Imaging DevelopmentOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00080353 | Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00295958 | LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00846833 | Haploidentical NK Cell Infusion in Malignant Melanoma | completed | Phase 1 / Phase 2 | 12 | Seoul National University HospitalOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00254579 | Study of CP-675,206 in Refractory Melanoma | completed | Phase 2 | 251 | AstraZenecaINDUSTRY | 9 | Jun 7, 2012 | clinicaltrials |
| NCT00281541 | A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma | completed | Phase 2 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01614301 | Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma | unknown | Phase 1 / Phase 2 | 136 | University of RegensburgOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00086489 | CP-675,206 In Patients With Advanced Melanoma | completed | Phase 2 | 118 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00431275 | Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody | completed | Phase 1 | 85 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00585000 | A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma | terminated | Phase 1 | 49 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT01026051 | Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma | terminated | Phase 2 | 5 | Mannkind CorporationINDUSTRY | 1 | May 15, 2012 | clinicaltrials |
| NCT00412425 | Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | completed | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00483301 | A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma | completed | Phase 2 | 34 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 3, 2012 | clinicaltrials |
| NCT00616564 | Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma | completed | Phase 2 | 36 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 3, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00369395 | A Study of Volociximab in Metastatic Melanoma | terminated | Phase 2 | 19 | AbbottINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00750399 | Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma | completed | Phase 1 | 10 | The New York Eye Cancer CenterOTHER | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00035165 | EPO906 Therapy in Patients With Advanced Melanoma | completed | Phase 2 | 51 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01584115 | Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) | unknown | Phase 1 / Phase 2 | 15 | Instituto de Investigação em ImunologiaOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01048554 | Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System(MEL0107) | completed | Phase 2 | 34 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01052142 | Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma | completed | Phase 1 | 12 | Lipotek Pty LtdINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00138229 | Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma | terminated | Phase 2 | 6 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00287131 | Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients | unknown | Phase 2 | 70 | Sheba Medical CenterOTHER_GOV | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00828126 | PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma | completed | — | 38 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00438984 | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 11 | Fred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00091104 | Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 136 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00316901 | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | completed | Phase 2 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00111696 | Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma | completed | Phase 1 | 18 | MedImmune LLCINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00542893 | A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine | completed | Phase 1 | — | Genta IncorporatedINDUSTRY | 0 | Mar 13, 2012 | clinicaltrials |
| NCT01003626 | Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Sep 24, 2012source: clinicaltrials